Tumor Immunity in the Peritoneal Cavity

  • Gideon Berke
  • Barbara Schick
Part of the Contemporary Topics in Immunobiology book series (CTI, volume 10)


Multicellular organisms are equipped with an intricate system to recognize and neutralize foreign and potentially dangerous components such as parasites, microorganisms, and neoplastic cells. However, many neoplastic tissues are capable of proliferative growth eventually leading to the death of the host, despite potential host antitumor cellular and humoral immunity. Inefficient antitumor activity is probably due to a complex series of events and factors that may include malfunction or suppression of host cells involved in antitumor responses and/or modification of tumor cells, for example, nonexpression or modification of antigenic determinants, inhibition of potential antitumor responses by antigen, sera, and/or tumor cell membrane complexes, accessibility of the tumor to components of the immune system, and a rate of tumor growth that outstrips the responses generated against it. An understanding of the characteristics, functions, and interactions of humoral and cellular host components involved in such responses might enable manipulation to benefit the individual.


Peritoneal Cavity Cytolytic Activity Tumor Immunity Peritoneal Cell Peritoneal Exudate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Allison, A.C., 1972, Immunity and immunopathology in virus infections, Ann. Inst. Pasteur, Paris 123: 585.Google Scholar
  2. Amos, D. B., 1960, Possible relations between the cytotoxic effects of isoantibody and host cell function, Ann. N.Y. Acad. Sci. 87: 273.CrossRefPubMedGoogle Scholar
  3. Amos, D. B., 1962a, Host response to ascites tumors, in: Mechanism of Cell and Tissue Damage Produced by Immune Reactions, p. 210, Benno Schwabe and Co., Basel, Switzerland.Google Scholar
  4. Amos, D. B., 1962b, The use of simplified systems as an aid to the interpretation of mechanisms of graft rejection, Prog. Allergy 6: 468.PubMedGoogle Scholar
  5. Amos, D. B., and Wakefield, J. D., 1959, Growth of ascites tumor cells in diffusion chambers. II. Lysis and growth inhibition by diffusible isoantibody, J. Natl. Cancer Inst. 22: 1077.PubMedGoogle Scholar
  6. Andersson, L. C., and Häyry, P., 1975, Clonal isolation of alloantigen-reactive T Cells and characterization of their memory, Transplant. Rev. 25: 121.PubMedGoogle Scholar
  7. Baker, P., Weiser, R. S., Jutila, J., Evans, C. A., and Blandau, R. J., 1962, Mechanisms of tumor homograft rejection: The behavior of Sarcoma I ascites tumor in the A/Jax and C57BL/6K mouse, Ann. N.Y. Acad. Sci. 101: 46.CrossRefGoogle Scholar
  8. Berke, G., 1980, Interaction of cytotoxic T lymphocytes and target cells, Prog. Allergy 27: 69–133.PubMedGoogle Scholar
  9. Berke, G., and Amos, D. B., 1973a, Mechanism of lymphocyte-mediated cytolysis: The LMC cycle and its role in transplantation, Transplant. Rev. 17: 71.PubMedGoogle Scholar
  10. Berke, G., and Amos, D. B., 1973b, Cytotoxic lymphocytes in the absence of detectable antibody, Nature (London) New Biol. 242: 237.CrossRefGoogle Scholar
  11. Berke, G., Sullivan, K., and Amos, D. B., 1972, Rejection of ascites tumor allografts. I. Isolation, characterization, and in vitro reactivity of peritoneal lymphoid effector cells from BALB/c mice immune to EL4 leukosis, J. Exp. Med. 135: 1334.CrossRefPubMedGoogle Scholar
  12. Berke, G., Gabison, D., and Feldman, M., 1975, The frequency of effector cells in populations containing cytotoxic T lymphocytes, Eur. J. Immunol. 5: 813.CrossRefGoogle Scholar
  13. Biddison, W. E., and Palmer, J. C., 1977, Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815, Proc. Nat. Acad. Sci. USA 74: 329.CrossRefPubMedGoogle Scholar
  14. Biddison, W. E., Palmer, J. C., Alexander, M. A., Cowan, E. P., and Manson, L. A., 1977, Characterization and specificity of murine anti-tumor cytotoxic effector cells within an ascitic tumor, J. Immunol. 118: 2243.PubMedGoogle Scholar
  15. Canty, T. G., and Wunderlich, J. R., 1971, Quantitative assessment of cellular and humoral responses to skin and tumor allografts, Transplantation 11: 111.CrossRefPubMedGoogle Scholar
  16. Cerottini, J. C., and Brunner, K. T., 1971, Cytotoxic lymphocytes as effector cells of cell-mediated immunity, in: Progress in Immunology, Vol. 1 ( D. B. Amos, ed.), p. 385, Academic Press, New York.Google Scholar
  17. Cerottini, J. C., and Brunner, K. T., 1974, Cell-mediated cytotoxicity, allograft rejection and tumor immunity, Adv. Immunol. 18: 67.CrossRefPubMedGoogle Scholar
  18. Cerottini, J. C., Engers, H. D., MacDonald, H. R., and Brunner, K. T., 1974, Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures, J. Exp. Med. 140: 703.CrossRefPubMedGoogle Scholar
  19. Cohen, I. R., and Livnat, S., 1976, The cell-mediated immune response: Interactions of initiator and recruited T lymphocytes, Transplant. Rev. 29: 24.Google Scholar
  20. Evans, R., 1972, Macrophages in syngeneic animal tumors, Transplantation 14: 468.CrossRefPubMedGoogle Scholar
  21. Evans, R., and Alexander, P., 1970, Cooperation of immune cells with macrophages in tumor immunity, Nature (London) 228: 620.CrossRefGoogle Scholar
  22. Ford, W. L.. 1975, Lymphocyte migration and immune responses, Prog. Allergy 19: 1.PubMedGoogle Scholar
  23. Golstein, P., and Smith, E. T., 1977, Mechanism of T- cell-mediatedcytolysis: The lethal hit stage, in: Contemporary Topics in Immunobiology, Vol. 7 (0. Stutman, ed.), pp. 273–300, Plenum Press, New York.CrossRefGoogle Scholar
  24. Gorer, D., 1956, Some recent work on tumor immunity, Adv. Cancer Res. 4: 149.CrossRefPubMedGoogle Scholar
  25. Hashimoto, Y., and Sudo, H., 1968, Studies on acquired transplantation resistance. III. Cytocidal effect of sensitized peritoneal lymphocytic cells of Donryu rats against the target Yoshida sarcoma cells in vitro, Gann 59: 7.PubMedGoogle Scholar
  26. Hashimoto, Y., Ishidate, M., and Takaku, M., 1965, Studies on acquired transplantation resistance. II. Action of peritoneal exudate cells of Donryu rats immune to the tumor against Yoshida sarcoma, Gann 56: 23.PubMedGoogle Scholar
  27. Haskill, J. S., Häyry, P., and Radov, L. A., 1978, Systemic and local immunity in allograft and cancer rejection, in: Contemporary Topics in Immunobiology, Vol. 8 ( N. L. Warner and M. D. Cooper, eds.), pp. 107–170, Plenum Press, New York.CrossRefGoogle Scholar
  28. Hellström, K. E., and Hellström, I., 1974, Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens, Adv. Immunol. 18: 209.CrossRefPubMedGoogle Scholar
  29. Henney, C. S., 1977, T- cell-mediatedcytolysis: An overview of some current issues, in: Contemporary Topics in Immunobiology, Vol. 7 (0. Stutman, ed.), pp. 245–272, Plenum Press, New York.CrossRefGoogle Scholar
  30. Herberman, R. B., 1974, Cell-mediated immunity to tumor cells, Adv. Cancer Res. 19: 207.CrossRefPubMedGoogle Scholar
  31. Herberman, R. B., Campbell, D. A., Oldham, R. K., Bonnard, G. D., Ting, C. C., Holden, H. T., Glaser, M., Djeu, J., and Oehler, R., 1976, Immunogenicity of tumor antigens, Ann. N.Y. Acad. Sci. 276: 26.CrossRefPubMedGoogle Scholar
  32. Johnson, T. S., Hudson, J. L., Feldman, M. E., and Irvin, G. L., 1975, Innumoprophylaxis and cytotoxic effector cells against EL4 leukemia induced in syngeneic C57BL/6J mice by use of irradiated EL4 cells, J. Natl. Cancer Inst. 55: 561.PubMedGoogle Scholar
  33. Klein, E., and Klein, G., 1972, Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and incompatible tumor cells, Cell. Immunol. 5: 201.CrossRefGoogle Scholar
  34. Klein, G., and Klein, E., 1956, Conversion of solid neoplasms into ascites tumors, Ann. N.Y. Acad. Sci. 63: 640.CrossRefPubMedGoogle Scholar
  35. Levy, M. H., Wheelock, E. F., 1974, The role of macrophages in defense against neoplastic diseases, Adv. Cancer Res. 20: 133.Google Scholar
  36. Martz, E., 1977, Mechanism of specific tumor cell lysis by alloimmune T lymphocytes: Resolution and characterization of discrete steps in the cellular interaction, in: Contemporary Topics in Immunobiology, Vol. 7 (0. Stutman, ed.), pp. 301–361, Plenum Press, New York.CrossRefGoogle Scholar
  37. Nowotny, A., Groshsman, J., Abdelnoor, A., Rote, N., Yang, C., and Waltersdorff, R., 1974, Escape of TA3 tumors from allogeneic immune rejection: Theory and experiments, Eur. J. Immunol. 4: 73.CrossRefPubMedGoogle Scholar
  38. Old, L. J., Boyse, E. A., Bennet, B., and Lilly, F., 1963, Peritoneal cells as an immune population in transplantation studies, in: Cell-Bound Antibodies ( B. Amos and H. Koprovski, eds.), p. 89, Wistar Press, Philadelphia.Google Scholar
  39. Patt, H. M., and Straube, R. L., 1956, Measurement and nature of ascites tumor growth, Ann. N.Y. Acad. Sci. 63: 728.CrossRefPubMedGoogle Scholar
  40. Pedersen, N. C., and Morris, B., 1970, The role of the lymphatic system in the rejection of homografts: A study of lymph from renal transplants, J. Exp. Med. 131: 936.CrossRefPubMedGoogle Scholar
  41. Raz, A., Goldman, R., Yuli, I., and Inbar, M., 1978, Isolation of plasma membrane fragments and vesicles from ascites fluid of lymphoma-bearing mice and their possible role in the escape mechanism of tumors from host immune rejection, Cancer Immunol. Immunother. 4: 53.CrossRefGoogle Scholar
  42. Roberts, P. J., and Häyry, P., 1977, Effector mechanism in allograft rejection. II. Density, electrophoresis, and size fractionation of allograft-infiltrating cells demonstrating several classes of killer cells, Cell. Immunol. 30: 326.CrossRefGoogle Scholar
  43. Russell, S. W., Doe, W. F., Hoskins, R. G., and Cochrane, C. G., 1976, Inflammatory cells in solid murine neoplasms. I. Tumor disaggregation and identification of constituent inflammatory cells, Int. J. Cancer 18: 322.CrossRefPubMedGoogle Scholar
  44. Schick, B., and Berke, G., 1977a, Activity of tumor-associated lymphoid cells at short intervals after administration of irradiated syngeneic and allogeneic tumor cells, J. Immunol. 118: 986.PubMedGoogle Scholar
  45. Schick, B., and Berke, G., 1977b, Tumor-associated lymphoid cells: Analysis of host cells that bind to syngeneic and allogeneic tumor cells shortly after tumor administration, Transplant. Proc. 9: 1157.PubMedGoogle Scholar
  46. Straube, R. L., Hill, M. S., and Patt, H. M., 1955, Vascular permeability and ascites tumor growth, Proc. Am. Assoc. Cancer Res. 2: 49.Google Scholar
  47. Strom, T. B., Tilney, N. L., Paradysz, J. M., Bancewicz, J., and Carpenter, C. B., 1977, Cellular components of allograft rejection: Identity, specificity, and cytotoxic function of cells infiltrating acutely rejecting allografts, J. Immunol. 118: 2020.Google Scholar
  48. Takasugi, M., and Klein, E., 1970, A microassay for cell-mediated immunity, Transplantation 9: 219.CrossRefPubMedGoogle Scholar
  49. Tracey, D. E., Pross, H. F., Jondal, M., and Witz, I. P., 1975, Antibody-dependent cell- mediated cytotoxic activity in syngeneic mouse ascites tumors, Int. J. Cancer 16: 870.CrossRefPubMedGoogle Scholar
  50. Van Blitterswijk, W. J., Emmelot, P., Hilkmann, H. A. M., Oomen-Meulemans, E. P. M., and Inbar, M., 1977, Differences in lipid fluidity among isolated plasma membranes of normal and leukemic lymphocytes and membranes exfoliated from their cell surface, Biochim. Biophys. Acta 467: 309.CrossRefPubMedGoogle Scholar
  51. Van Blitterswijk, W. J., Emmelot, P., Hilkmann, H. A., Hilgers, J., and Feltkamp, C. A., 1979, Rigid plasma-membrane-derived vesicles enriched in tumor associated surface antigens (MLr) occurring in the ascites-fluid of a murine leukemia (GRSL), Int. J. Cancer 23: 62.CrossRefPubMedGoogle Scholar
  52. Wagner, H., and Röllinghoff, M., 1973, In vitro induction of tumor-specific immunity. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors, J. Exp. Med. 138: 1.Google Scholar
  53. Waksman, B. H., 1970, Atlas of Experimental Immunobiology and Immunopathology, Yale University Press, New Haven and London.Google Scholar
  54. Waksman, B. H., 1974, The antiallograft response effector mechanism, in: Progress in Immunology, Vol. 5 ( L. Brent and E. J. Holbrow, eds.), p. 127, North-Holland, Amsterdam.Google Scholar
  55. Weaver, J. M., 1958, Destruction of mouse ascites tumor cells in vivo and in vitro by homologous macrophages, lymphocytes, and cell-free antibodies, Proc. Am. Assoc. Cancer Res. 2: 354.Google Scholar
  56. Wilson, D. B., and Billingham, R. E., 1967, Lymphocytes and transplantation immunity, Adv. Immunol. 7: 189.CrossRefPubMedGoogle Scholar
  57. Zbar, B., Wepsic, H. T., Borsos, T., and Rapp, H. J., 1970, Tumor-graft rejection in syngeneic guinea pigs, Evidence for a two-step mechanism, J. Natl. Cancer Inst. 44: 473.PubMedGoogle Scholar
  58. Zettergren, J. G., Luberoff, D. E., and Pretlow, T. G., 1973, Separation of lymphocytes from disaggregated mouse malignant neoplasms by sedimentation in gradients of Ficoll in tissue culture medium, J. Immunol. 111: 836.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1980

Authors and Affiliations

  • Gideon Berke
    • 1
  • Barbara Schick
    • 1
  1. 1.Department of Cell BiologyThe Weizmann Institute of ScienceRehovotIsrael

Personalised recommendations